Eczema Topical Spray Study
We know these are challenging times and venturing out can be especially stressful. We want you to know that at CRCC we have implemented every safety measure possible to keep you safe and prevent the spread of Covid-19. Patient areas are continually disinfected, social distancing is enforced in our lobby, and all staff wear masks/gloves throughout the day. If you arrive for your appointment and wish to wear a mask, we will provide one for you as well.
About Atopic Dermatitis
Eczema/Atopic Dermatitis is a complex disease that is determined by genetic, environmental, and immunologic factors. It is one of the most common chronic medical diseases that is characterized by redness, itching, thickening of the skin, and crusted areas. Flares are frequently triggered by exposure to environmental factors, irritants, and allergens. Patients may have a high disease burden and their life quality is significantly affected.
About the Study
This study accesses the effectiveness of a topical spray to relieve itching.
Am I Eligible?
- Must 18-65 years of age
- Itching has lasted for at least 4 weeks prior to screening
- Itching must be worse than 7 on the rating scale, 24 hours prior to screening
- Must have a 12-month diagnosis of AD
- BSA must be 10-40%
- Compensation may be available for time/travel
If you are interested in participating in one of these studies, please provide your contact information below. If you are a qualified candidate, a representative from our research department will be in touch with you.